Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, China.
Department of Radiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
J Cancer Res Clin Oncol. 2023 Jul;149(7):4025-4039. doi: 10.1007/s00432-022-04295-5. Epub 2022 Aug 29.
Primary pulmonary salivary gland-type tumor (PSGT) included two main subtypes, pulmonary adenoid cystic carcinoma (PACC) and pulmonary mucoepidermoid carcinoma (PMEC). The purpose of this study was to compare the similarities and differences between these two subtypes and to identify independent risk factors for the prognosis of PSGT patients.
This study screened patients with a pathological diagnosis of PSGT in Beijing Chaoyang Hospital between 2010 and 2021. The clinical, pathological, radiological, laboratory test, and other characteristics were collected, and t, nonparametric and chi-squared tests were used to compare the differences in clinical characteristics of the two subtypes. COX univariate and multivariate analyses were used to explore prognostic-related risk factors.
A total of 62 patients with PSGT were included in our center over a 12-year period. There were 26 PMEC patients and 36 PACC patients. There were differences in the clinical, pathological, and radiological features of the two tumor subtypes. Univariate analysis showed that weight loss, chemotherapy, white blood cells, lymphocytes, red blood cells, total protein, and total bilirubin might be related to the prognosis in PSGT patients. Multivariate results showed that lymphocytes (p = 0.031), red blood cells (p = 0.047), total protein (p = 0.032), and total bilirubin (p = 0.010) were independent prognostic risk factors. Chemotherapy (HR 4.452; 95% CI 1.723-11.503; p = 0.002) might be associated with progression-free survival (PFS).
The two subtypes of PSGT had significantly different clinical, laboratory, pathological, and radiological features. However, there was no significant difference in the prognosis of patients with PMEC and PACC subtypes. Cox univariate and multivariate analyses showed that levels of lymphocytes, erythrocytes, total protein and total bilirubin in the peripheral blood of PSGT patients might be related to patient overall survival. Chemotherapy might also be associated with PFS.
原发性肺涎腺型肿瘤(PSGT)包括肺腺样囊性癌(PACC)和肺黏液表皮样癌(PMEC)两个主要亚型。本研究旨在比较这两种亚型的异同,并确定 PSGT 患者预后的独立危险因素。
本研究筛选了 2010 年至 2021 年期间在北京朝阳医院病理诊断为 PSGT 的患者。收集了临床、病理、影像学、实验室检查等特征,并采用 t 检验、非参数检验和卡方检验比较了两种亚型临床特征的差异。采用 COX 单因素和多因素分析探讨了预后相关的危险因素。
本中心在 12 年间共纳入 62 例 PSGT 患者,其中 PMEC 患者 26 例,PACC 患者 36 例。两种肿瘤亚型在临床、病理和影像学特征上存在差异。单因素分析显示,体重减轻、化疗、白细胞、淋巴细胞、红细胞、总蛋白和总胆红素可能与 PSGT 患者的预后有关。多因素结果显示,淋巴细胞(p=0.031)、红细胞(p=0.047)、总蛋白(p=0.032)和总胆红素(p=0.010)是独立的预后危险因素。化疗(HR 4.452;95%CI 1.723-11.503;p=0.002)可能与无进展生存期(PFS)相关。
PSGT 的两种亚型在临床、实验室、病理和影像学特征上存在显著差异,但 PMEC 和 PACC 亚型患者的预后无显著差异。Cox 单因素和多因素分析显示,PSGT 患者外周血淋巴细胞、红细胞、总蛋白和总胆红素水平可能与患者总生存期有关。化疗也可能与 PFS 相关。